3-Arylidene-5-(4-isobutylphenyl)-2(3H)-furanones: a new series of anti-inflammatory and analgesic compounds having antimicrobial activity

被引:6
作者
Alam, Mumtaz Mohammad [1 ]
Husain, Asif [1 ]
Hasan, Syed M. [2 ]
Khanna, Suruchi [3 ]
Shaquiquzzaman, Mohammad [1 ]
机构
[1] Jamia Hamdard, Fac Pharm, Dept Pharmaceut Chem, New Delhi 110062, India
[2] Coll Hlth Sci, Dept Pharm, Sakaka, Saudi Arabia
[3] Jamia Hamdard, Fac Pharm, Dept Pharmacol, New Delhi 110062, India
关键词
Furanones; anti-inflammatory; ulcerogenic; lipid peroxidation; antimicrobial activity; BIOLOGICAL EVALUATION; CYCLOOXYGENASE-2; DERIVATIVES; INHIBITORS; DESIGN; DRUGS; 2(3H)-FURANONES; LACTONES; DAMAGE; ASSAY;
D O I
10.3109/14756360903179435
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
An ideal anti-inflammatory drug should have the desired effect in minimum dose with minimum side effects. Antimicrobial actions associated with such agents will be an added advantage as they broaden the spectrum of the compounds. Promising anti-inflammatory and antimicrobial activity together with low ulcerogenic properties of some 2(3H)-furanones, synthesized in our previous study, prompted us to investigate the effect of the isobutyl group on their pharmacological profile. Since compounds 3, 9, 13, and 14 have both anti-inflammatory and analgesic effects in addition to low ulcerogenic incidence, they were selected for investigation of their inhibitory effects on various cyclo-oxygenase enzymes. It was found that they were more selective toward COX-2 enzymes. An MIC of 6.25 mu g/mL was recorded for compounds 3, 13, and 14 against S. aureus, E. coli, R. oryza, and P. citrum. The study supports the development of furanone derivatives as potential anti-inflammatory agents with antimicrobial activity.</.
引用
收藏
页码:323 / 330
页数:8
相关论文
共 27 条
[1]
Synthesis and pharmacological evaluation of 2(3H)-furanones and 2(3H)-pyrrolones, combining analgesic and anti-inflammatory properties with reduced gastrointestinal toxicity and lipid peroxidation [J].
Alam, M. M. ;
Husain, Asif ;
Hasan, S. M. ;
Suruchi ;
Anwer, T. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (06) :2636-2642
[2]
Synthesis and cytotoxic activity of γ-aryl substituted α-alkylidene-γ-lactones and α-alkylidene-γ-lactams [J].
Albrecht, Anna ;
Koszuk, Jacek F. ;
Modranka, Jakub ;
Rozalski, Marek ;
Krajewska, Urszula ;
Janecka, Anna ;
Studzian, Kazimierz ;
Janecki, Tomasz .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (09) :4872-4882
[3]
GASTROINTESTINAL DAMAGE ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
ALLISON, MC ;
HOWATSON, AG ;
TORRANCE, CJ ;
LEE, FD ;
RUSSELL, RI .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (11) :749-754
[4]
Synthesis and biological activities of a series of 4,5-diaryl-3-hydroxy-2(5H)-furanones [J].
Bailly, Fabrice ;
Queffelec, Clemence ;
Mbemba, Gladys ;
Mouscadet, Jean-Francois ;
Pommery, Nicole ;
Pommery, Jean ;
Henichart, Jean-Pierre ;
Cotelle, Philippe .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (06) :1222-1229
[5]
Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents [J].
Bekhit, AA ;
Abdel-Aziem, T .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (08) :1935-1945
[6]
3,4-diaryl-5-hydroxyfuranones:: Highly selective inhibitors of cyclooxygenase-2 with aqueous solubility [J].
Black, WC ;
Brideau, C ;
Chan, CC ;
Charleson, S ;
Cromlish, W ;
Gordon, R ;
Grimm, EL ;
Hughes, G ;
Leger, S ;
Li, CS ;
Riendeau, D ;
Thérien, M ;
Wang, ZY ;
Xu, LJ ;
Prasit, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (06) :1195-1198
[7]
ROLE OF DIRECT TISSUE CONTACT IN THE PRODUCTION OF GASTRO-INTESTINAL ULCERS BY ANTI-INFLAMMATORY DRUGS IN RATS [J].
CIOLI, V ;
ROSSI, V ;
PUTZOLU, S ;
BARCELLONA, PS ;
CORRADINO, C .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1979, 50 (02) :283-289
[8]
Cruickshank R., 1975, Medicinal Microbiology, VII, P196
[9]
The development of COX2 inhibitors [J].
Flower, RJ .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (03) :179-191
[10]
Synthesis and biological activity of new anti-inflammatory compounds containing the 1,4-benzodioxine and/or pyrrole system [J].
Harrak, Y. ;
Rosell, G. ;
Daidone, G. ;
Plescia, S. ;
Schillaci, D. ;
Pujol, M. D. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (14) :4876-4890